Clinical Trial Update: Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating the safety and immunogenicity of cancer vaccines aimed at preventing glioblastoma recurrence. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Unspecified cancer vaccine(s) for glioblastoma

Snippet

Sponsor: Beijing Neurosurgical Institute | Conditions: Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Glioblastom WHO Grade 4 | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION